Vista previa del material en texto
Genetic architecture of Alzheimer`s disease
AD Risk
APP/PS
mutations
TOMM40
APOE4
+/+ TOMM40
APOE4
+/- PICALM
MS4A
BIN
ABAC7
CR1
Discovery of novel drug targets
Development of predictive diagnosis tests
CLU
APOE2
CD33
AD Protection